Covered recipient · General Payments record
NATHAN ANDREW THOLL
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2019–2024
$2,156.70
- Reported across 147 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $215.89 | 13 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $182.33 | 11 |
| Lilly USA, LLC | $33.56 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (13)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Lilly USA, LLC | $18.31 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135271855 | CMS |
| Lilly USA, LLC | $15.25 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135238144 | CMS |
| Novo Nordisk Inc | $19.90 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097835992 | CMS |
| Novo Nordisk Inc | $19.90 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097320815 | CMS |
| Novo Nordisk Inc | $18.17 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097317933 | CMS |
| Novo Nordisk Inc | $18.54 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097124426 | CMS |
| Novo Nordisk Inc | $20.74 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096842317 | CMS |
| Novo Nordisk Inc | $24.22 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096580225 | CMS |
| Novo Nordisk Inc | $17.69 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097500758 | CMS |
| Novo Nordisk Inc | $21.22 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097655704 | CMS |
| Novo Nordisk Inc | $4.60 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096920004 | CMS |
| Novo Nordisk Inc | $9.50 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097299071 | CMS |
| Novo Nordisk Inc | $7.85 | 12/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097697853 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.